Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Dalton T, Doubrovina E, Pankov D, Reynolds R, Scholze H, Selvakumar A, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 2020;135(21):1870-1881.

Magruder M, Edusei E, Zhang L, Albakry S, Satlin MJ, Westblade LF, et al. Gut commensal microbiota and decreased risk for bacteriuria and urinary tract infection. Gut Microbes. 2020;12(1):1805281.

Magro CM, J Mulvey J, Laurence J, Seshan S, A Crowson N, Dannenberg AJ, et al. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019. Hum Pathol. 2020;106:106-116.

Zhou P, Yan F. CRL4 Ubiquitin Pathway and DNA Damage Response. Adv Exp Med Biol. 2020;1217:225-239.

Huang T-, Fowler F, Chen C-, Shen Z-, Sleckman B, Tyler JK. The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading onto ssDNA during Homologous Recombination in Human Cells. Mol Cell. 2020;77(5):1153.

Itkonen HM, Poulose N, Steele RE, Martin SE, Levine ZG, Duveau DY, et al. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. Mol Cancer Res. 2020;18(10):1512-1521.

Limberg J, Barker K, Hoda S, Simmons R, Michaels A, Marti JL. Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary? World J Surg. 2020;44(5):1552-1558.

Magro C, Schwartz Z, Saab J, Hedayat A. Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos disease. Ann Diagn Pathol. 2020;44:151414.

van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020;4(23):6039-6050.

Schwartz Z, Bender A, Magro CM. Solitary congenital Langerhans cell histiocytoma: A pattern of benign, spontaneous regression in patients with single lesion disease. Pediatr Dermatol. 2020;37(6):1009-1013.